Filing Details
- Accession Number:
- 0001437749-20-003172
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-20 16:39:03
- Reporting Period:
- 2020-02-20
- Accepted Time:
- 2020-02-20 16:39:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 810509 | Navidea Biopharmaceuticals Inc. | NAVB | In Vitro & In Vivo Diagnostic Substances (2835) | 311080091 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1554593 | Jed Latkin | 4995 Bradenton Ave., Suite 240 Dublin OH 43017 | Ceo, Coo & Cfo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-20 | 5,000 | $1.08 | 17,950 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
